Literature DB >> 3389929

Anticardiolipin antibodies in patients with primary immunodeficiency diseases.

D Pascual-Salcedo1, M C García Rodríguez, M López Trascasa, G Fontán.   

Abstract

The presence of antibodies to cardiolipin was determined (by an ELISA) in 143 patients with primary immunodeficiency diseases. Thirty (21%) had raised anticardiolipin antibody levels compared with only three in 98 age matched controls. The highest prevalence of this autoantibody was found in the Wiskott-Aldrich syndrome. Patients with selective IgA deficiency also showed a high prevalence of this autoantibody (32%), while patients with severe defects in antibody production showed a low prevalence or did not have such autoantibodies. This study provides further evidence of the association between autoimmune phenomena and primary immunodeficiency diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3389929      PMCID: PMC1003535          DOI: 10.1136/ard.47.5.410

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  10 in total

1.  THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS.

Authors:  E J BOWIE; J H THOMPSON; C A PASCUZZI; C A OWEN
Journal:  J Lab Clin Med       Date:  1963-09

2.  Immunofluorescence tests in immune technics and applications.

Authors:  E V Barnett
Journal:  Am J Clin Pathol       Date:  1977-11       Impact factor: 2.493

3.  Autoimmune hemolytic anemia in Wiskott-Aldrich syndrome during treatment with transfer factor.

Authors:  M Ballow; B Dupont; R A Good
Journal:  J Pediatr       Date:  1973-11       Impact factor: 4.406

4.  Antiphospholipid antibodies in acute Guillain-Barré syndrome.

Authors:  E N Harris; H Englert; G Derve; G R Hughes; A Gharavi
Journal:  Lancet       Date:  1983-12-10       Impact factor: 79.321

Review 5.  Annotation. Fibrosis of the bone marrow: content and causes.

Authors:  D M McCarthy
Journal:  Br J Haematol       Date:  1985-01       Impact factor: 6.998

6.  Anticardiolipin antibodies: occurrence in Behçet's syndrome.

Authors:  R G Hull; E N Harris; A E Gharavi; A Tincani; R A Asherson; G Valesini; A M Denman; G Froude; G R Hughes
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

7.  Antibodies to nucleic acids in congenital immune deficiency states.

Authors:  M E Gershwin; R M Blaese; A D Steinberg; R Wistar; W Strober
Journal:  J Pediatr       Date:  1976-09       Impact factor: 4.406

8.  Autoimmunity in selective IgA deficiency.

Authors:  J V Wells; D Michaeli; H H Fudenberg
Journal:  Birth Defects Orig Artic Ser       Date:  1975

9.  Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome.

Authors:  L G Lum; D G Tubergen; L Corash; R M Blaese
Journal:  N Engl J Med       Date:  1980-04-17       Impact factor: 91.245

10.  Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome.

Authors:  J M Zabay; G Fontán; A Campos; M C García-Rodriguez; D Pascual-Salcedo; A Bootello; E G de la Concha
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.